Last reviewed · How we verify
NCT05441293
Determinants of the Success of Flap Reconstruction: Outcome Analysis of 484 Surgeries for Pressure Injury
trial testing flap reconstruction in Pressure Injury in 484 participants. Completed in 31 May 2022.
1 December 2021
Quick facts
| Lead sponsor | Taipei Medical University WanFang Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 484 |
| Start date | 1 January 2016 |
| Primary completion | 1 December 2021 |
| Estimated completion | 31 May 2022 |
Drugs / interventions tested
- flap reconstruction
Conditions studied
- Pressure Injury — all drugs for Pressure Injury →
Sponsor
Taipei Medical University WanFang Hospital
Who can join
20 and older, any sex, with Pressure Injury. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: Pressure injury (PI) mainly occurs in bedridden older adults or those with physical limitations. PI treatment is typically long-term, requiring coordination between health-care workers and the patient's caregiver. Here, we aimed to determine the appropriate timing to conduct flap reconstruction in patients with PIs and identify factors affecting surgical outcomes. Materials and Methods: We retrospectively reviewed the data of all patients who received debridement or flap reconstruction surgery for PIs in our hospital from January 2016 to December 2021. The extracted data included patient demographics, surgical records, blood test results, vital signs, and flap outcomes. Next, these characteristics including the flap outcomes of our patients with PIs were analyzed, along with the risk factors for poor wound healing and complications.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Determinants of the success in flap reconstruction-Outcome analysis of 120 flaps in 484 procedures for pressure injury.
Huang CY, Lee SL, Chiu WK, Chen C, et al · · 2023 · cited 6× · PMID 37157923 · DOI 10.1111/iwj.14185
Verify or expand the search:
- PubMed search for NCT05441293
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pressure Injury
Currently open trials in the same condition.
- NCT07306143 — Prediction of Pressure Injury Risk in ICU Using Data Mining · recruiting
- NCT07158658 — Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Chronic Pressure Ulcers · NA · recruiting
- NCT06977152 — Comparison of the Effectiveness of Fluidized Positioner and Memory Foam Pillow in the Prevention of Pressure Injury in t · NA · recruiting
- NCT06954857 — The Influence of Standardized Process Management of Laryngeal Mask Airway Placement Based on Pressure Monitoring on the · NA · recruiting
- NCT06529094 — Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Sp · NA · recruiting
Other Taipei Medical University WanFang Hospital trials
Trials by the same sponsor.
- NCT07401017 — The Effects of Rosuvastatin on Running Training Adaptation and Safety · NA · not yet recruiting
- NCT07293442 — Pelvic Floor Muscle Exercise for Lower Urinary Tract Symptoms After Surgery for Benign Prostatic Hyperplasia. · NA · recruiting
- NCT07150182 — Shared Decision-Making for Families in Critical Dialysis Initiation · NA · not yet recruiting
- NCT06834425 — Efficacy of NSAID Peritendinous Injection for Acute Tendinitis · NA · active not recruiting
- NCT06862297 — Prospective Study Between Polysomnography (PSG) and Novel Ultrasonic Jaw Tracking Device in Patients with Sleep Apnea · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05441293 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Taipei Medical University WanFang Hospital
- Last refreshed: 1 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05441293.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing